Hepcidin in anemia of chronic kidney disease: Review for the pediatric nephrologist

Pediatric Nephrology

Volumn 27, Issue 1, 2012, Pages 33-40

  Atkinson, Meredith A ^a   White, Colin T ^b  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

Anemia; Erythropoiesis stimulating agent; Hepcidin; Iron

Indexed keywords

ANTIANEMIC AGENT; HEPCIDIN; IRON;

ANEMIA; CHILD; CHRONIC KIDNEY DISEASE; ERYTHROCYTE; ERYTHROPOIESIS; GLOMERULUS FILTRATION RATE; HUMAN; INFLAMMATION; INTESTINE; IRON ABSORPTION; IRON DEFICIENCY; IRON METABOLISM; IRON STORAGE; IRON TRANSPORT; KIDNEY FAILURE; PEDIATRICS; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN STRUCTURE; REVIEW; UPREGULATION;

ANEMIA, IRON-DEFICIENCY; ANTIMICROBIAL CATIONIC PEPTIDES; CHRONIC DISEASE; DRUG RESISTANCE; HEMATINICS; HUMANS; IRON; KIDNEY DISEASES; UP-REGULATION;

EID: 83655192890     PISSN: 0931041X     EISSN: 1432198X     Source Type: Journal    
DOI: 10.1007/s00467-011-1832-y     Document Type: Review

References (50)

1. JW Eschbach JC Egrie MR Downing JK Browne JW Adamson 1987 Correction of the anemia of end-stage renal disease with recombinant human erythropoietin. Results of a combined phase I and II clinical trial N Engl J Med 316 2 73 78 3537801 1:STN:280:DyaL2s%2FmsFSjsw%3D%3D 10.1056/NEJM198701083160203 (Pubitemid 17052741)
2. JW Eschbach JW Adamson 1999 Iron overload in renal failure patients: changes since the introduction of erythropoietin therapy Kidney Int Suppl 69 S35 S43 10084284 1:CAS:528:DyaK1MXhvVSnurg%3D 10.1046/j.1523-1755.1999.055Suppl. 69035.x
3. Guyton AC, Hall JE (2000) Textbook of medical physiology, 10th edn. Saunders, Philadelphia
4. Geary DF, Schaefer F (2008) Comprehensive pediatric nephrology. Mosby/Elsevier, Philadelphia
5. MA Atkinson K Martz BA Warady AM Neu 2010 Risk for anemia in pediatric chronic kidney disease patients: a report of NAPRTCS Pediatr Nephrol 25 9 1699 1706 20464428 10.1007/s00467-010-1538-6
6. OF Bamgbola FJ Kaskel M Coco 2009 Analyses of age, gender and other risk factors of erythropoietin resistance in pediatric and adult dialysis cohorts Pediatr Nephrol 24 3 571 579 18800231 10.1007/s00467-008-0954-3
7. MA Pfeffer EA Burdmann CY Chen ME Cooper D de Zeeuw KU Eckardt JM Feyzi P Ivanovich R Kewalramani AS Levey EF Lewis JB McGill JJ McMurray P Parfrey HH Parving G Remuzzi AK Singh SD Solomon R Toto TREAT Investigators 2009 A trial of darbepoetin alfa in type 2 diabetes and chronic kidney disease N Engl J Med 361 21 2019 2032 19880844 10.1056/NEJMoa0907845
8. EF Unger AM Thompson MJ Blank R Temple 2010 Erythropoiesis-stimulating agents-time for a reevaluation N Engl J Med 362 3 189 192 20054037 1:CAS:528:DC%2BC3cXosV2iug%3D%3D 10.1056/NEJMp0912328
9. RS Gillespie FM Wolf 2004 Intravenous iron therapy in pediatric hemodialysis patients: a meta-analysis Pediatr Nephrol 19 6 662 666 15052462 10.1007/s00467-004-1421-4 (Pubitemid 38771739)
10. National Kidney Foundation 2006 KDOQI clinical practice guidelines and clinical practice recommendations for anemia in chronic kidney disease Am J Kidney Dis 47 5S3 S11 S145
11. GJ Handelman NW Levin 2009 Iron and anemia in human biology: a review of mechanisms Heart Fail Rev 13 4 393 404 10.1007/s10741-008-9086-x
12. LT Goodnough E Nemeth T Ganz 2010 Detection, evaluation, and management of iron-restricted erythropoiesis Blood 116 23 4754 4761 20826717 1:CAS:528:DC%2BC3cXhs1Slsr3L 10.1182/blood-2010-05-286260
13. CN Roy NC Andrews 2005 Anemia of inflammation: the hepcidin link Curr Opin Hematol 12 2 107 111 15725899 1:CAS:528:DC%2BD2MXis12nt74%3D 10.1097/00062752-200503000-00001 (Pubitemid 40315693)
14. G Weiss LT Goodnough 2005 Anemia of chronic disease N Engl J Med 52 10 1011 1023 10.1056/NEJMra041809 (Pubitemid 40349504)
15. C Thomas L Thomas 2005 Anemia of chronic disease: pathophysiology and laboratory diagnosis Lab Hematol 1 1 14 23 10.1532/LH96.04049 (Pubitemid 40444028)
16. J Malyszko M Mysliwiec 2007 Hepcidin in anemia and inflammation in chronic kidney disease Kidney Blood Press Res 30 1 15 30 17215586 1:CAS:528:DC%2BD2sXhslCks7c%3D 10.1159/000098522
17. Kalantar-Zadeh K, Lee GH (2006) The fascinating but deceptive ferritin: to measure it or not to measure it in chronic kidney disease? Clin J Am Soc Nephrol Suppl 1:S9-S18
18. JL Babitt HY Lin 2010 Molecular mechanisms of hepcidin regulation: implications for the anemia of CKD Am J Kidney Dis 55 4 726 741 20189278 1:CAS:528:DC%2BC3cXlsFSlsLw%3D 10.1053/j.ajkd.2009.12.030
19. NC Andrews 2008 Forging a field: the golden age of iron biology Blood 112 2 219 230 18606887 1:CAS:528:DC%2BD1cXos1Cisbk%3D 10.1182/blood-2007-12-077388
20. J Braun K Lindner M Schreiber RA Heidler WH Horl 1997 Percentage of hypochromic red blood cells as predictor of erythropoietic and iron response after i.v. iron supplementation in maintenance haemodialysis patients Nephrol Dial Transplant 12 6 1173 1181 9198047 1:STN:280:DyaK2szktFyhtw%3D%3D 10.1093/ndt/12.6.1173 (Pubitemid 27230553)
21. National Kidney Foundation 2007 KDOQI clinical practice cuideline and clinical practice recommendations for anemia in chronic kidney disease: 2007 update of hemoglobin target Am J Kidney Dis 50 3 471 530 10.1053/j.ajkd.2007.06. 008 (Pubitemid 47285453)
22. R Agarwal 2008 Iron, oxidative stress, and clinical outcomes Pediatr Nephrol 23 8 1195 1199 18030498 10.1007/s00467-007-0673-1
23. S Fishbane 2008 Upper limit of serum ferritin: misinterpretation of the 2006 KDOQI anemia guidelines Semin Dial 21 3 217 220 18248518 10.1111/j.1525-139X.2007.00420.x
24. M Franchini M Montagnana G Lippi 2010 Hepcidin and iron metabolism: From laboratory to clinical implications Clin Chim Acta 411 21-22 1565 1569 20620132 1:CAS:528:DC%2BC3cXhtFGht7fN 10.1016/j.cca.2010.07.003
25. J Zaritsky B Young HJ Wang M Westerman G Olbina E Nemeth T Ganz S Rivera AR Nissenson IB Salusky 2009 Hepcidin-a potential novel biomarker for iron status in chronic kidney disease Clin J Am Soc Nephrol 4 6 1051 1056 19406957 1:CAS:528:DC%2BD1MXnsF2rtbk%3D 10.2215/CJN.05931108
26. DR Ashby DP Gale M Busbridge KG Murphy ND Duncan TD Cairns DH Taube SR Bloom FW Tam RS Chapman PH Maxwell P Choi 2009 Plasma hepcidin levels are elevated but responsive to erythropoietin therapy in renal disease Kidney Int 75 9 976 981 19212416 1:CAS:528:DC%2BD1MXks1SjsLc%3D 10.1038/ki.2009.21
27. DW Swinkels JF Wetzels 2008 Hepcidin: a new tool in the management of anaemia in patients with chronic kidney disease? Nephrol Dial Transplant 23 8 2450 2453 18495744 1:CAS:528:DC%2BD1cXptlylsLs%3D 10.1093/ndt/gfn267
28. EH Kemna H Tjalsma HL Willems DW Swinkels 2008 Hepcidin: from discovery to differential diagnosis Haematologica 93 1 90 97 18166790 1:CAS:528: DC%2BD1cXitVOhs7o%3D 10.3324/haematol.11705 (Pubitemid 351156156)
29. T Ganz G Olbina D Girelli E Nemeth M Westerman 2008 Immunoassay for human serum hepcidin Blood 112 10 4292 4297 18689548 1:CAS:528:DC%2BD1cXhsVSmsrjJ 10.1182/blood-2008-02-139915
30. E Nemeth 2010 Targeting the hepcidin-ferroportin axis in the diagnosis and treatment of anemias Adv Hematol 10.1155/2010/750643
31. CN Roy HH Mak I Akpan G Losyev D Zurakowski NC Andrews 2007 Hepcidin antimicrobial peptide transgenic mice exhibit features of the anemia of inflammation Blood 109 9 4038 4044 17218383 1:CAS:528:DC%2BD2sXkvFCiu70%3D 10.1182/blood-2006-10-051755 (Pubitemid 46641759)
32. J Malyszko JS Malyszko K Pawlak M Mysliwiec 2006 Hepcidin, iron status, and renal function in chronic renal failure, kidney transplantation, and hemodialysis Am J Hematol 81 11 832 837 16929540 1:CAS:528:DC%2BD28Xht1Oisb7P 10.1002/ajh.20657 (Pubitemid 44682184)
33. J Malyszko JS Malyszko P Kozminski M Mysliwiec 2009 Type of renal replacement therapy and residual renal function may affect prohepcidin and hepcidin Ren Fail 31 10 876 883 20030521 1:CAS:528:DC%2BD1MXhs1aqtLnK 10.3109/08860220903216071
34. RT Means 2004 Hepcidin and cytokines in anaemia Hematology 9 5-6 357 362 15763974 1:CAS:528:DC%2BD2cXhtFCqurfI 10.1080/10245330400018540 (Pubitemid 40123584)
35. E Nemeth S Rivera V Gabayan C Keller S Taudorf BK Pedersen T Ganz 2004 IL-6 mediates hypoferremia of inflammation by inducing the synthesis of the iron regulatory hormone hepcidin J Clin Invest 113 9 1271 1276 15124018 1:CAS:528:DC%2BD2cXjvVOqsrY%3D (Pubitemid 39069926)
36. VS Balakrishnan D Guo M Rao BL Jaber H Tighiouart RL Freeman C Huang AJ King BJ Pereira HEMO Study Group 2004 Cytokine gene polymorphisms in hemodialysis patients: association with comorbidity, functionality, and serum albumin Kidney Int 65 4 1449 1460 15086488 1:CAS:528:DC%2BD2cXjtF2js7Y%3D 10.1111/j.1523-1755.2004.00531.x (Pubitemid 38406987)
37. S Poole TA Bird S Selkirk RE Gaines-Das Y Choudry SL Stephenson AJ Kenny J Saklatvaa 1990 Fate of injected interleukin 1 in rats: sequestration and degradation in the kidney Cytokine 2 6 416 422 2104235 1:CAS:528: DyaK3MXlsFKktrY%3D 10.1016/1043-4666(90)90050-4
38. MH Bemelmans DJ Gouma WA Buurman 1993 Influence of nephrectomy on tumor necrosis factor clearance in a murine model J Immunol 150 5 2007 2017 8436831 1:CAS:528:DyaK3sXhvV2ksLk%3D (Pubitemid 23129679)
39. D Zwolinska A Medynska K Szprynger M Szczepanska 2000 Serum concentration of IL-2, IL-6, TNF-alpha and their soluble receptors in children on maintenance hemodialysis Nephron 86 4 441 446 11124592 1:CAS:528:DC%2BD3MXjt1Srsg%3D%3D 10.1159/000045832 (Pubitemid 32010729)
40. SL Goldstein JC Leung DM Silverstein 2006 Pro- and anti-inflammatory cytokines in chronic pediatric dialysis patients: effect of aspirin Clin J Am Soc Nephrol 1 5 979 986 17699316 1:CAS:528:DC%2BD28XpvFOqsLc%3D 10.2215/CJN.02291205
41. R Pecoits-Filho LC Sylvestre P Stenvinkel 2005 Chronic kidney disease and inflammation in pediatric patients: from bench to playground Pediatr Nephrol 20 6 714 720 15856313 10.1007/s00467-005-1891-z (Pubitemid 40663151)
42. LC Sylvestre KP Fonseca AE Stinghen AM Pereira RP Meneses R Pecoits-Filho 2007 The malnutrition and inflammation axis in pediatric patients with chronic kidney disease Pediatr Nephrol 22 6 864 873 17340148 10.1007/s00467-007-0429-y (Pubitemid 46629623)
43. BP Oberg E McMenamin FL Lucas E McMonagle J Morrow TA Ikizler J Himmelfarb 2004 Increased prevalence of oxidant stress and inflammation in patients with moderate to severe chronic kidney disease Kidney Int 65 3 1009 1016 14871421 10.1111/j.1523-1755.2004.00465.x (Pubitemid 38251077)
44. K Kalantar-Zadeh CJ McAllister RS Lehn GH Lee AR Nissenson JD Kopple 2003 Effect of malnutrition-inflammation complex syndrome on EPO hyporesponsiveness in maintenance hemodialysis patients Am J Kidney Dis 42 4 761 773 14520627 10.1016/S0272-6386(03)00915-6 (Pubitemid 37187377)
45. B Young J Zaritsky 2009 Hepcidin for clinicians Clin J Am Soc Nephrol 4 8 1384 1387 19556376 1:CAS:528:DC%2BD1MXhtV2qurrN 10.2215/CJN.02190309
46. N Tessitore D Girelli N Campostrini V Bedogna G Pietro Solero A Castagna E Melilli W Mantovani G De Matteis O Olivieri A Poli A Lupo 2010 Hepcidin is not useful as a biomarker for iron needs in haemodialysis patients on maintenance erythropoiesis-stimulating agents Nephrol Dial Transplant 25 12 3996 4002 20538788 1:CAS:528:DC%2BC3cXhsFSgtr%2FK 10.1093/ndt/gfq321
47. G Weiss I Theurl S Eder C Koppelstaetter K Kurz T Sonnweber U Kobold G Mayer 2009 Serum hepcidin concentration in chronic haemodialysis patients: associations and effects of dialysis, iron and erythropoietin therapy Eur J Clin Invest 39 10 883 890 19563467 1:CAS:528:DC%2BD1MXhtlWhsrvI 10.1111/j.1365-2362. 2009.02182.x
48. J Zaritsky B Young B Gales HJ Wang A Rastogi M Westerman E Nemeth T Ganz IB Salusky 2010 Reduction of Serum Hepcidin by Hemodialysis in Pediatric and Adult Patients Clin J Am Soc Nephrol 5 6 1010 1014 20299375 10.2215/CJN.08161109
49. T Ganz E Nemeth 2009 Iron sequestration and anemia of inflammation Semin Hematol 46 4 387 393 19786207 1:CAS:528:DC%2BD1MXhtlehtbbJ 10.1053/j. seminhematol.2009.06.001
50. H Kawabata N Tomosugi J Kanda Y Tanaka K Yoshizaki T Uchiyama 2007 Anti-interleukin 6 receptor antibody tocilizumab reduces the level of serum hepcidin in patients with multicentric Castleman's disease Haematologica 92 6 857 858 17550864 1:CAS:528:DC%2BD2sXhtFGqu7rJ 10.3324/haematol.10794 (Pubitemid 350155317)